Jean-Marc Brondello

INSERM, Rennes, Bretagne, France 
"Jean-Marc Brondello"
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Pichard L, Brondello JM, Becker F, et al. (2021) Establishment of a collection of human pluripotent stem cell lines (iPSC) from mesenchymal stem cells (MSC) from three healthy elderly donors. Stem Cell Research. 53: 102297
Veret D, Jorgensen C, Brondello JM. (2020) Osteoarthritis in time for senotherapeutics. Joint Bone Spine. 88: 105084
Veret D, Brondello JM. (2020) [Senotherapy: Advances and new clinical perspectives]. Medecine Sciences : M/S. 36: 1135-1142
Brondello JM, Pers YM. (2019) Taking in consideration the bystander effects of articular senescence. Annals of Translational Medicine. 7: S386
Malaise O, Tachikart Y, Constantinides M, et al. (2019) Mesenchymal stem cell senescence alleviates their intrinsic and seno-suppressive paracrine properties contributing to osteoarthritis development. Aging. 11
Brondello JM, Djouad F, Jorgensen C. (2019) Where to Stand with Stromal Cells and Chronic Synovitis in Rheumatoid Arthritis? Cells. 8
Luz-Crawford P, Hernandez J, Djouad F, et al. (2019) Mesenchymal stem cell repression of Th17 cells is triggered by mitochondrial transfer. Stem Cell Research & Therapy. 10: 232
Tachikart Y, Malaise O, Mumme M, et al. (2019) Seno-suppressive molecules as new therapeutic perspectives in rheumatic diseases. Biochemical Pharmacology
Malaise O, Tachikart Y, Constantinides M, et al. (2019) Op0071 Revealing The Link Between Osteoarthritis Development And Mesenchymal Stem Cell Senescence Annals of the Rheumatic Diseases
Tachikart Y, Malaise O, Constantinides M, et al. (2018) [Senescent cells: a target in osteo-articular diseases]. Medecine Sciences : M/S. 34: 547-553
See more...